Literature DB >> 19020866

Persistence of one-trial cocaine-induced behavioral sensitization in young rats: regional differences in Fos immunoreactivity.

Sanders A McDougall1, Sergios Charntikov, Anthony M Cortez, Dionisio A Amodeo, Cynthia E Martinez, Cynthia A Crawford.   

Abstract

RATIONALE: Unlike adult rats, young rats exhibit context-dependent and context-independent behavioral sensitization when assessed after a single pretreatment injection of cocaine.
OBJECTIVE: The purpose of this study was to determine whether: (1) the context-dependent and context-independent sensitization of young rats can be dissociated based on the persistence of the sensitized response and (2) the expression of behavioral sensitization is associated with region-specific increases in Fos immunoreactivity (Fos-IR).
MATERIALS AND METHODS: On postnatal day (PD) 19, rats were injected with either saline or cocaine (30 mg/kg) in a novel test chamber or the home cage. After 1, 3, 5, 7, 14, or 61 abstinence days, rats were challenged with 20 mg/kg cocaine and locomotor activity was measured for 60 min. In a separate experiment, rats pretreated on PD 19 were challenged with cocaine (10-30 mg/kg) on PD 80.
RESULTS: The sensitized responding of young rats persisted for the same length of time (5 days) regardless of whether cocaine pretreatment occurred in a novel environment or the home cage. Behavioral sensitization did not reemerge in adulthood. When assessed after three abstinence days (i.e., on PD 22), acute treatment with cocaine increased Fos-IR in various brain regions, but sensitized responding was associated with elevated Fos expression in only the caudate-putamen (CP) and prefrontal cortex (PFC).
CONCLUSIONS: Persistence of the sensitized response cannot be used to dissociate the one-trial context-dependent and context-independent sensitization of young rats. Fos data indicate that the CP and PFC may be involved in the mediation of short-term behavioral sensitization on PD 22.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19020866     DOI: 10.1007/s00213-008-1407-1

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  50 in total

1.  Withdrawal duration differentially affects c-fos expression in the medial prefrontal cortex and discrete subregions of the nucleus accumbens in cocaine-sensitized rats.

Authors:  M S Todtenkopf; A Mihalakopoulos; J R Stellar
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

Review 2.  Ontogenesis of behavioral sensitization and conditioned place preference induced by psychostimulants in laboratory rodents.

Authors:  Ezio Tirelli; Giovanni Laviola; Walter Adriani
Journal:  Neurosci Biobehav Rev       Date:  2003 Jan-Mar       Impact factor: 8.989

3.  Cocaine conditioning and cocaine sensitization: what is the relationship?

Authors:  R J Carey; J Gui
Journal:  Behav Brain Res       Date:  1998-04       Impact factor: 3.332

4.  Amphetamine-induced conditioned activity and sensitization: the role of habituation to the test context and the involvement of Pavlovian processes.

Authors:  E Tirelli; P Terry
Journal:  Behav Pharmacol       Date:  1998-09       Impact factor: 2.293

5.  D1 and D2 dopamine receptors differentially increase Fos-like immunoreactivity in accumbal projections to the ventral pallidum and midbrain.

Authors:  G S Robertson; M Jian
Journal:  Neuroscience       Date:  1995-02       Impact factor: 3.590

6.  Principles and pitfalls in the analysis of prenatal treatment effects in multiparous species.

Authors:  R R Holson; B Pearce
Journal:  Neurotoxicol Teratol       Date:  1992 May-Jun       Impact factor: 3.763

7.  Longevity of the expression of behavioral sensitization to cocaine in preweanling rats.

Authors:  K J Snyder; N M Katovic; L P Spear
Journal:  Pharmacol Biochem Behav       Date:  1998-08       Impact factor: 3.533

8.  Compartment-specific changes in striatal neuronal activity during expression of amphetamine sensitization are the result of drug hypersensitivity.

Authors:  Louk J M J Vanderschuren; Anton N M Schoffelmeer; Sarah D C Van Leeuwen; Liesbeth Hof; Allert J Jonker; Pieter Voorn
Journal:  Eur J Neurosci       Date:  2002-12       Impact factor: 3.386

9.  Two dissociable components of behavioral sensitization following repeated amphetamine administration.

Authors:  N J Leith; R Kuczenski
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

10.  Context modulates the expression of conditioned motor sensitization, cellular activation and synaptophysin immunoreactivity.

Authors:  David J Rademacher; T Celeste Napier; Gloria E Meredith
Journal:  Eur J Neurosci       Date:  2007-10-26       Impact factor: 3.386

View more
  10 in total

1.  Ontogeny of methamphetamine-induced and cocaine-induced one-trial behavioral sensitization in preweanling and adolescent rats.

Authors:  Olga O Kozanian; Arnold Gutierrez; Alena Mohd-Yusof; Sanders A McDougall
Journal:  Behav Pharmacol       Date:  2012-08       Impact factor: 2.293

2.  One-trial cocaine-induced behavioral sensitization in preweanling rats: role of contextual stimuli.

Authors:  Matthew S Herbert; Taleen Der-Ghazarian; Alexandria G Palmer; Sanders A McDougall
Journal:  Exp Clin Psychopharmacol       Date:  2010-06       Impact factor: 3.157

3.  One-trial behavioral sensitization in preweanling rats: differential effects of cocaine, methamphetamine, methylphenidate, and D-amphetamine.

Authors:  Sanders A McDougall; Olga O Kozanian; Venuz Y Greenfield; Leslie R Horn; Arnold Gutierrez; Alena Mohd-Yusof; Kevin A Castellanos
Journal:  Psychopharmacology (Berl)       Date:  2011-05-03       Impact factor: 4.530

4.  Importance of associative learning processes for one-trial behavioral sensitization of preweanling rats.

Authors:  Sanders A McDougall; Alexandria G Pothier; Taleen Der-Ghazarian; Matthew S Herbert; Olga O Kozanian; Kevin A Castellanos; Ana T Flores
Journal:  Behav Pharmacol       Date:  2011-10       Impact factor: 2.293

5.  Effects of repeated treatment with the 5-HT1A and 5-HT1B agonists (R)-( +)-8-hydroxy-DPAT and CP-94253 on the locomotor activity and axillary temperatures of preweanling rats: evidence of tolerance and behavioral sensitization.

Authors:  Sanders A McDougall; Jordan A Taylor; Matthew J Roe; Constance J Greenwood
Journal:  Psychopharmacology (Berl)       Date:  2021-11-24       Impact factor: 4.530

6.  Effects of D2 or combined D1/D2 receptor antagonism on the methamphetamine-induced one-trial and multi-trial behavioral sensitization of preweanling rats.

Authors:  Alena Mohd-Yusof; Ana Veliz; Krista N Rudberg; Michelle J Stone; Ashley E Gonzalez; Sanders A McDougall
Journal:  Psychopharmacology (Berl)       Date:  2015-12-09       Impact factor: 4.530

7.  Importance of D1 and D2 receptor stimulation for the induction and expression of cocaine-induced behavioral sensitization in preweanling rats.

Authors:  Sanders A McDougall; Krista N Rudberg; Ana Veliz; Janhavi M Dhargalkar; Aleesha S Garcia; Loveth C Romero; Ashley E Gonzalez; Alena Mohd-Yusof; Cynthia A Crawford
Journal:  Behav Brain Res       Date:  2017-03-08       Impact factor: 3.332

8.  Role of the D1 receptor for the dopamine agonist-induced one-trial behavioral sensitization of preweanling rats.

Authors:  Alena Mohd-Yusof; Ashley E Gonzalez; Ana Veliz; Sanders A McDougall
Journal:  Psychopharmacology (Berl)       Date:  2014-04-17       Impact factor: 4.530

9.  Importance of environmental context for one- and three-trial cocaine-induced behavioral sensitization in preweanling rats.

Authors:  Sanders A McDougall; Anthony M Cortez; Alexandria G Palmer; Matthew S Herbert; Cynthia E Martinez; Sergios Charntikov; Dionisio A Amodeo
Journal:  Psychopharmacology (Berl)       Date:  2009-07-28       Impact factor: 4.530

10.  Chronic nicotine alters cannabinoid-mediated locomotor activity and receptor density in periadolescent but not adult male rats.

Authors:  Linda L Werling; Stephanie Collins Reed; Dean Wade; Sari Izenwasser
Journal:  Int J Dev Neurosci       Date:  2009-01-10       Impact factor: 2.457

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.